Ultragenyx Pharmaceutical | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Insmed USD 340.96M 6.11M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Kyowa Hakko Kirin JPY 97.3B 5.6B 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Moderna USD 1.16B 1.06B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Ultragenyx Pharmaceutical Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.